DIRS.INFO The most relevant business & tech news

☆ McKinsey tried to boost the morale of senior staff by blasting Eminem and Bob Marley at an internal event, report says
▼ + stars: | 2024-04-30 | by ( Polly Thompson | ) www.businessinsider.com time to read: +3 min

McKinsey & Co. held an internal event to rally partners amid a challenging year, Bloomberg reports. Like many major consulting firms, McKinsey has announced layoffs as demand for its services has fallen. During the event, Bob Sternfels, global managing partner at McKinsey, reportedly admitted that the last 18 months had been challenging but said that 2024 was looking better for the firm. McKinsey global managing partner, Bob Sternfels, makes a statement to the US Senate on the firm's work with Saudi Arabia, February 2024. But McKinsey partners have reportedly been unhappy with how leadership has handled the role reductions, people familiar with the matter told Bloomberg.

Persons: Bob Marley, Eminem, —, Bob Sternfels, Sternfels, sprees, they're Organizations: McKinsey, Co, Bloomberg, Service, SPAN McKinsey, Employees, US Department of Justice, Purdue Pharma, Sternfels Locations: British, Copenhagen, Saudi Arabia

☆ McKinsey advised drug companies on how to 'turbocharge' opioid sales. Now it's under criminal investigation.
▼ + stars: | 2024-04-25 | by ( Meghan Morris | ) www.businessinsider.com time to read: +3 min

The Department of Justice is investigating McKinsey for advising opioid producers on boosting sales. The firm previously paid nearly $1 billion to resolve lawsuits related to its opioid work. The investigation is also looking at potential obstruction of justice by McKinsey and its employees. News of the investigation underscores how McKinsey's opioid work — which the firm said it stopped in 2019 — continues to plague the consultancy. In a 2018 email, for example, a since-fired McKinsey executive wrote to another senior executive about the firm's legal risk.

Persons: —, Endo, Martin Elling Organizations: Justice, McKinsey, Service, McKinsey & Company, US Department of Justice, Street, Purdue Pharma, DOJ, of, Purdue Locations: Virginia, Western, of Virginia, of Massachusetts, Seattle

The Justice Department is investigating McKinsey & Company, the international consulting giant, for its role in helping drug companies maximize their sale of opioids. Since 2021, McKinsey has agreed to pay about $1 billion to settle investigations and lawsuits across the United States related to the firm’s work with opioid makers, principally Purdue Pharma, the maker of OxyContin. McKinsey recommended that Purdue “turbocharge” its sales of the drug in the midst of the opioid crisis, which has killed hundreds of thousands of Americans. News of the criminal investigation was first reported by The Wall Street Journal on Wednesday. Last year another opioid maker, Mallinckrodt, said it received a grand jury subpoena from the same U.S. attorney’s office but did not mention any connection to McKinsey.

Persons: Endo, Mallinckrodt Organizations: McKinsey & Company, U.S, Western, of, McKinsey, Purdue Pharma, Purdue “ turbocharge, Wall, The New York Times Locations: Massachusetts, of Virginia, Washington, United States

☆ National Sciences Academy Asks Court to Strip Sackler Name From Endowment
▼ + stars: | 2024-04-12 | by ( Christina Jewett | ) www.nytimes.com time to read: +1 min

The National Academy of Sciences is asking a court to allow it to repurpose about $30 million in donations from the wealthy Sackler family, who controlled the company at the center of the opioid epidemic, and to remove the family name from the endowment funds. The petition filed by the Academy in Superior Court in Washington, D.C., Thursday aims to modify the terms of the donations so the institution can use them for scientific studies, projects and educational activities. The move follows a report in The New York Times last year that examined donations from several Sackler members, including an executive of Purdue Pharma, which produced the painkiller OxyContin that has long been blamed for fueling the opioid crisis that has claimed thousands of lives. “The notoriety of the Sackler name has made it impossible for the Academy to carry out the purposes for which it originally accepted the funds,” Marcia McNutt, president of the National Academy of Sciences, said in a statement released on Thursday.

Persons: Sackler, ” Marcia McNutt Organizations: National Academy of Sciences, Academy, Washington , D.C, The New York Times, Sackler, Purdue Pharma Locations: Superior Court, Washington ,, The

☆ Supreme Court Allows $2.4 Billion Boy Scouts Sex Abuse Deal to Go Forward
▼ + stars: | 2024-02-22 | by ( Abbie Vansickle | More About Abbie Vansickle | ) www.nytimes.com time to read: 1 min

The Supreme Court cleared the way on Thursday for a $2.4 billion plan to settle sex abuse lawsuits against the Boy Scouts of America to go forward. The court’s brief, unsigned order gave no reasons, which is typical for emergency applications. There were no public dissents. A group of victims had asked the court to pause the plan as the justices consider an opioid settlement against Purdue Pharma, the manufacturer of OxyContin, and the members of the wealthy Sackler family who owned it, because that deal raised similar issues. Like the Purdue Pharma deal, the Boy Scouts agreement was settled in bankruptcy court using a contentious mechanism that insulates a third party from future lawsuits even without requiring that party to declare bankruptcy.

Persons: Sackler Organizations: Boy Scouts of, Purdue Pharma, Boy Scouts Locations: Boy Scouts of America

Guidepost didn't immediately respond to an email asking whether Morris & Dickson remains a client. Neither the DEA or Morris & Dickson immediately responded to a request for comment. While Morris & Dickson has managed to stay open, several of the pharmacies it supplied have closed, had their licenses revoked by the DEA or have been criminally prosecuted. Yet Morris & Dickson never suspended any shipments to the pharmacy. Over three years, it filed just three suspicious order reports to the DEA – none of which resulted in shipments being suspended.

Persons: Anne Milgram, Morris, Charles Dorman, Milgram's, Louis Milione, Milione, Morris & Dickson, Guidepost didn't, Dickson, ”, Katherine Pfaff, Judge Dorman, Wilkinson, Keith Wilkinson laundered, ___ Goodman Organizations: U.S . Drug, Morris, Dickson Co, Associated Press, AP, DEA, Morris & Dickson, Purdue Pharma, Guidepost Solutions, Morris &, Wilkinson Family Locations: Shreveport, La, New York, Morris, New Orleans, Miami, Mustian, Investigative@ap.org

☆ An OxyContin advertiser will pay $350 million in the first-ever opioid marketing settlement
▼ + stars: | 2024-02-01 | by ( David Goldman | ) edition.cnn.com time to read: +3 min

Publicis, a French marketing company, agreed to pay $350 million within the next two months and will not take on any more opioid clients, according to New York Attorney General Letitia James. “For a decade, Publicis helped opioid manufacturers like Purdue Pharma convince doctors to overprescribe opioids, directly fueling the opioid crisis and causing the devastation of communities nationwide,” said James in a statement. For its alleged role in the opioid crisis, McKinsey in 2021 agreed to pay $573 million to states as part of multiple settlements. “The fight against the opioid crisis in the United States requires collaboration across industries, lawmakers, and communities, and we are committed to playing our part. Purdue Pharma first introduced the opioid drug OxyContin in the 1990s and promoted it as non-addictive.

Persons: Letitia James, Phil Weiser, Publicis, ”, James, ” Publicis, Sackler Organizations: New, New York CNN, Purdue Pharma’s, New York, Colorado, Purdue Pharma, McKinsey, Purdue, Centers for Disease Control, Biden, Sackler Locations: New York, French, United States

It is the first advertising company to reach a major settlement over the toll of opioids in the U.S. It faced a lawsuit in at least Massachusetts but settled with most states before they made court claims against it. James' office said the materials played up the abuse-deterrent properties of OxyContin and promoted increasing patients' doses. As part of the settlement, Publicis agreed to release internal documents detailing its work for Purdue and other companies that made opioids. The first began after OxyContin hit the market in 1996 and was linked mostly to prescription opioids, many of them generics.

Persons: Letitia James, Publicis, James, Bob Ferguson, Rosetta, ” Publicis, Sackler, OxyContin Organizations: Publicis, Publicis Groupe, New York, Purdue Pharma, Washington, Purdue, State Pharmacy, U.S, Supreme Locations: Paris, U.S, Massachusetts, Connecticut

☆ Institutions Are (Quietly) Taking Sackler Money
▼ + stars: | 2024-01-25 | by ( Alex Marshall | ) www.nytimes.com time to read: +1 min

When arts organizations began shunning the Sackler family over its role in the U.S. opioid crisis, it wasn’t just American institutions that cut ties. Museums in Britain that had accepted Sackler largess were among the first to take action. After the National Portrait Gallery in London canceled a $1.3 million Sackler donation in 2019, the Tate museum group announced it would not seek any more of the family’s support. Other museums began discussing removing the Sackler name from their walls. According to the Sackler Trust’s latest accounts, which were published this month, the nonprofit committed around 5.2 million pounds, or $6.6 million, in 2022, comprising 66 grants to institutions.

Persons: Sackler, — Organizations: Museums, Tate, Sackler Trust —, Purdue Pharma, Sackler Locations: U.S, Britain, London, British

☆ Supreme Court Weighs Purdue Pharma’s $6 Billion Opioid Settlement
▼ + stars: | 2023-12-05 | by ( Jess Bravin | ) www.wsj.com time to read: +1 min

Purdue Pharma headquarters in 2019; a Purdue lawyer said in court Monday that if a settlement with the company didn’t go forward, opioid-crisis victims might not see compensation. Photo: timothy a. clary/Agence France-Presse/Getty ImagesWASHINGTON—Supreme Court justices wrestled Monday with the uncomfortable bargain struck between most victims of the opioid crisis and the Sackler family, whose Purdue Pharma promoted the addictive painkiller OxyContin: providing timely compensation for survivors in exchange for granting the wealthy family immunity from future civil lawsuits. That settlement was reached before a bankruptcy judge and approved in May by a federal appeals court in New York. It would see the Sacklers pay $6 billion to individual victims and state governments in exchange for eliminating potential liability for additional claims, such as fraud—even though they, unlike Purdue, haven’t sought bankruptcy protection. The deal was made under a catchall provision of federal law authorizing bankruptcy judges to issue orders and judgments that may be “necessary or appropriate” to resolve cases.

Persons: timothy, clary, Sackler, haven’t Organizations: Purdue Pharma, Purdue, Agence France, Getty, WASHINGTON Locations: New York

☆ Purdue mess pits drug victims against due process
▼ + stars: | 2023-12-05 | by ( Robert Cyran | ) www.reuters.com time to read: +3 min

That’s the dilemma currently facing the parties involved in the case regarding Purdue Pharma, including states, individuals, and the company’s founding Sackler family. According to the lawsuit, the family withdrew $11 billion from Purdue, but only contributed $6 billion to the settlement. Side with the DOJ, and the Supreme Court could clean up the bankruptcy process that often shields individuals and companies. For now, though, either the victims of the opioid epidemic will have to wait, or those wanting to end bankruptcy shields will. Follow @rob_cyran on XCONTEXT NEWSThe Supreme Court heard arguments on Dec. 4 over whether to approve the Purdue Pharmaceuticals bankruptcy agreement.

Persons: Sackler, Elena Kagan, Neil Gorsuch, Kagan, Gorsuch, Brett Kavanaugh, They’ve, Lauren Silva Laughlin, Sharon Lam Organizations: Reuters, U.S, Supreme, Purdue Pharma, U.S . Department of Justice, Purdue, Liberal, DOJ, Purdue Pharmaceuticals, Thomson

☆ Supreme Court to Hear Challenge to Controversial Purdue Pharma Deal
▼ + stars: | 2023-12-04 | by ( Abbie Vansickle | More About Abbie Vansickle | ) www.nytimes.com time to read: +1 min

Purdue Pharma and the wealthy family that controlled it are forever linked to the deadly opioid epidemic, which has left hundreds of thousands of people dead. But their role in the public health crisis is not the central question that the Supreme Court will wrestle with on Monday when it hears arguments over a bankruptcy settlement involving Purdue, the maker of the highly addictive painkiller OxyContin. Instead, the justices will focus on a narrower issue: whether the plan, devised to address the thousands of claims brought by state and local governments, tribes, hospitals and individual victims, can give wide-ranging legal protections to members of the Sackler family, the owners of the company. Under the deal, the Sacklers would pay up to $6 billion of their fortune toward settling those claims in exchange for immunity from all civil legal disputes related to the opioid crisis and Purdue.

Persons: Sackler Organizations: Purdue Pharma, Purdue

WASHINGTON (AP) — The Supreme Court is hearing arguments over a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids. The agreement hammered out with state and local governments and victims would provide billions of dollars to combat the opioid epidemic. Sackler family members no longer are on the company's board and they have not received payouts from it since before Purdue Pharma entered bankruptcy. In the decade before that, though, they were paid more than $10 billion, about half of which family members said went to pay taxes. A decision in Harrington v. Purdue Pharma, 22-859, is expected by early summer.

Persons: Sackler, Biden, Trump, ” OxyContin Organizations: WASHINGTON, Purdue Pharma, U.S, Bankruptcy, Justice Department, Purdue Locations: Stamford , Connecticut, Harrington

☆ US Supreme Court to scrutinize controversial opioid crisis settlement that would give Sackler family immunity
▼ + stars: | 2023-12-04 | by ( Samantha Delouya | ) edition.cnn.com time to read: +7 min

Barring individual victims from pursuing their own lawsuits against the Sackler family “raises serious constitutional questions,” the department argued. OxyContin’s commercial success helped the Sackler family earn billions of dollars and the family became known for philanthropy around the world. As the country’s opioid crisis worsened, attention shifted to the role played by Purdue Pharma and the Sackler family. Many of the suits allege that the Sackler family knew of OxyContin’s addictive properties but, nevertheless, continued to promote the drug. The Supreme Court hearing comes at a time of devastating losses due to drug overdoses in the US.

Persons: Los Angeles CNN —, Sackler, Mortimer, Raymond Sackler, “, George Frey, Elizabeth Prelogar, ” Anthony Casey, , –, Purdue Frederick, ” Lindsey Simon, ” Organizations: Los Angeles CNN, Purdue, New, US, US Justice Department, Purdue Pharma, Supreme, Knoa Pharma, Purdue Pharma L.P, Bloomberg, Sackler, ”, University of Chicago, school’s, Law, Finance, Guggenheim, Centers for Disease Control, “, Emory University Locations: New York, Purdue, Provo , Utah, U.S, United States, Paris

☆ Supreme Court questions opioid liability protections for Sackler family
▼ + stars: | 2023-12-04 | by ( Lawrence Hurley | ) www.cnbc.com time to read: +4 min

WASHINGTON — Members of the Supreme Court seemed conflicted on Monday over whether to allow the bankruptcy reorganization of opioid maker Purdue Pharma, which includes a provision that protects the Sackler family from liability from future lawsuits. During the oral argument, justices expressed skepticism that a bankruptcy court had legal authority to release the Sacklers from potential legal claims. No Sackler family member has had any involvement in the company since 2019. The company sought bankruptcy protection, but the Sackler family members did not. She added that it would be "an extraordinary thing" if the court allowed the family to "basically subvert" the bankruptcy process.

Persons: Sackler, Pharm, Biden, Neil Gorsuch, Brett Kavanaugh, Elena Kagan's, Kagan, Pratik Shah, Elizabeth Prelogar Organizations: WASHINGTON, Purdue Pharma, New York's Southern, Federal Court, Purdue Locations: New York's, White Plains

At issue is whether U.S. bankruptcy law allows Purdue's restructuring to include legal protections for the members of the Sackler family, who have not filed for personal bankruptcy. Members of the Sackler family have denied wrongdoing but expressed regret that OxyContin "unexpectedly became part of an opioid crisis." They said in May that the bankruptcy settlement would provide "substantial resources for people and communities in need." The administration told the Supreme Court that Purdue's settlement is an abuse of bankruptcy protections meant for debtors in "financial distress," not people like the Sacklers. The administration has also alleged that the Sackler family members withdrew $11 billion from Purdue before agreeing to contribute $6 billion to its opioid settlement.

Persons: painkiller, George Frey, Joe Biden's, Sackler, Biden, OxyContin, John Kruzel, Andrew Chung, Will Dunham Organizations: Purdue Pharma L.D, REUTERS, Rights, Purdue Pharma, WASHINGTON, U.S, Supreme, Purdue, Circuit, Thomson Locations: Provo , Utah, U.S, Stamford , Connecticut, Manhattan

☆ The oxycontin-peddling Sackler family has tried to get immunity from civil lawsuits by filing for bankruptcy. That might be illegal.
▼ + stars: | 2023-12-03 | by ( Katie Balevic | ) www.businessinsider.com time to read: +3 min

The US Supreme Court will decide whether Purdue Pharma's bankruptcy settlement will stand. Officially referred to as third-party nonconsensual releases, the legal maneuver allows organizations to settle personal injury claims in bankruptcy court instead of civil court. Legal experts say companies are more often relying on bankruptcy court than civil court to settle claims, The New York Times reported. Opponents of the practice say it robs regular people of their day in civil court. The Sacklers' settlement deal did not require the Sacklers themselves to declare bankruptcy, just Purdue Pharma, according to the Times.

Persons: Sackler, — Organizations: Purdue, Service, Purdue Pharma, Reuters, The New York Times, Times

☆ At Core of Purdue Pharma Case: Who Can Get Immunity in Settlements?
▼ + stars: | 2023-12-03 | by ( Abbie Vansickle | More About Abbie Vansickle | ) www.nytimes.com time to read: +1 min

For years, Purdue Pharma, the maker of the prescription painkiller OxyContin, had been entangled in lawsuits seeking to hold it to account for its role in the spiraling opioid crisis. A pathbreaking settlement reached last year appeared to signal the end to thousands of those cases, funneling billions of dollars toward fighting the epidemic in exchange for exempting members of the billionaire Sackler family, which once controlled the company, from civil lawsuits. But on Monday, the Supreme Court will hear arguments over whether the agreement is a violation of federal law in a case that could have ramifications not just for Purdue but also for organizations that turn to bankruptcy court, as the company did, to resolve claims of mass injury. “There’s huge implications for all of corporate bankruptcy,” said Anthony J. Casey, a law professor at the University of Chicago. “I think this is probably the most important bankruptcy case before the court in 30, maybe 40 years.”

Persons: Sackler, “, ”, Anthony J, Casey Organizations: Purdue Pharma, Purdue, University of Chicago

☆ Explainer: How will the Supreme Court reshape US opioid epidemic relief?
▼ + stars: | 2023-12-03 | by ( John Kruzel | ) www.reuters.com time to read: +5 min

The settlement also would shield the Stamford, Connecticut-based pharmaceutical company's wealthy Sackler family owners from lawsuits brought by opioid victims. A U.S. bankruptcy court approved that restructuring plan in 2021. Lawsuits against Purdue and Sackler family members accuse them of fueling the opioid epidemic through deceptive marketing of its pain medication. They said in May that the bankruptcy settlement would provide "substantial resources for people and communities in need." The administration also has said Sackler family members withdrew $11 billion from Purdue before agreeing to contribute $6 billion to the opioid settlement.

Persons: OxyContin, Sackler, Department's, Joshua Silverstein, Silverstein, Joe Biden's, John Kruzel, Dietrich Knauth, Will Dunham Organizations: Purdue Pharma, WASHINGTON, U.S, Supreme, Purdue, U.S ., District of Columbia, University of Arkansas, Justice Department, Thomson Locations: Stamford , Connecticut, United States, U.S, Little, New York

The Supreme Court is set to hear arguments Dec. 4 over whether the agreement, part of the resolution of Purdue Pharma's bankruptcy, violates federal law. She initially opposed the deal with Purdue Pharma but has come around. The Purdue Pharma settlement would be among the largest. But in the decade before that, they were paid more than $10 billion, about half of which family members said went to pay taxes. The department and Purdue Pharma forged a plea bargain in a criminal and civil case.

Persons: Sackler, Ellen Isaacs ’, Ryan Wroblewski, ”, Mike Quinn, ” Lynn Wencus, Jeff, ” Wencus, It's, General Merrick Garland, Donald Trump, Joe Biden, Purdue Pharma’s, ” ___ Mulvihill Organizations: WASHINGTON, Purdue Pharma, Purdue, Sackler, Bankruptcy, Justice Department, Republican, Democrat, Congress, Boy Scouts of, Boy Scout, Catholic, “ Locations: Florida, Wrentham , Massachusetts, Stamford , Connecticut, ”, Boy Scouts of America, Cherry Hill , New Jersey

☆ Giving Thanks When the World is on Fire
▼ + stars: | 2023-11-22 | by ( Amanda Taub | ) www.nytimes.com time to read: +3 min

I am thankful that my children have never felt the pain of burying a beloved sibling. Thankful that if we needed a hospital, it would have electricity and sterile equipment and supplies like anesthesia available. Thankful that my children are alive. But also sad and angry that we live in a world where these things are blessings to be counted, and where so many cannot do so. I want to hear about things you have read (or watched or listened to) that have had the biggest impact on you this year.

Persons: Jenny Sidhu, Barbara Kingsolver, Beth Macy, Dopesick Organizations: Purdue Pharma Locations: Gaza, Israel, Lebanon, Rocklin, Calif

☆ Curtain comes up on new term for conservative US Supreme Court
▼ + stars: | 2023-10-02 | by ( John Kruzel | ) www.reuters.com time to read: +4 min

The U.S. Supreme Court building is seen in Washington, U.S., August 31, 2023. The conservative justices have shown assertiveness in major rulings in the past two years. The court has ended its recognition of a constitutional right to abortion, expanded gun rights, restricted federal agency powers, rejected affirmative action in college admissions and broadened religious rights. The justices are opening their annual term on the first Monday of October, in keeping with tradition. The term debuts with some justices under ethics scrutiny after revelations this year of their ties to wealthy conservative benefactors.

Persons: Kevin Wurm, Joe Biden's, Mark Pulsifer, Donald Trump, Pulsifer, Ruth Bader Ginsburg, Trump, Amy Coney Barrett, Ginsburg, John Kruzel, Will Dunham Organizations: U.S, Supreme, REUTERS, Rights, Purdue, Republican, resentencing, Consumer Financial Protection Bureau, Securities and Exchange Commission, U.S . Postal, Thomson Locations: Washington , U.S, Iowa, Texas, Florida

On the heels of that decision, a federal appeals court invalidated a federal law that bars an individual who is subject to a domestic violence restraining order from possessing a firearm. A three-judge district court panel struck down the plan in January, saying that race had been the predominant motivating factor. Three years ago, the Supreme Court limited the independence of the CFPB by invalidating its leadership structure. The court’s decision could impact whether the SEC and other agencies can conduct enforcement proceedings in-house, using administrative courts staffed with agency employees, or whether such actions must be brought in federal court. “It’s difficult to think of any other recent First Amendment cases in which the stakes were so high,” Jaffer added.

Persons: Clarence Thomas, ”, Biden, Zackey Rahimi, John Roberts, Taiwan Scott, Thomas, Elizabeth Prelogar, Magnuson, Paul Clement, ” Clement, “, pare, George Jarkesy, Sackler, ” Prelogar, Jameel Jaffer, Jaffer Organizations: CNN, Gun Safety, South Carolina’s Republican, South Carolina State Conference of, NAACP, Democrat, Republican, National Marine Fisheries Service, Chevron, Natural Resources Defense, Stevens Fishery Conservation, Management, Independent, Consumer Financial, Federal Reserve, US, Federal Deposit Insurance Corporation, Securities, Exchange, US Securities and Exchange Commission, SEC, Social Security Administration, Circuit, Historic Purdue Pharma, Purdue Pharma, Sackler, Purdue, Facebook, YouTube, Columbia University’s Locations: United States, South Carolina, Alabama, Taiwan, Charleston County, Chevron, Florida, Texas

Bottles of prescription painkiller OxyContin made by Purdue Pharma LP sit on a shelf at a local pharmacy in Provo, Utah, U.S., April 25, 2017. The settlements, which require a judge's approval, were disclosed in papers filed on Tuesday in federal court in San Francisco. The money is on top of $641.5 million that McKinsey already paid to resolve claims by state attorneys-general. McKinsey will pay $207 million to resolve claims by counties and municipalities, and another $23 million to resolve claims by public school districts. Aelish Baig, a lawyer for the local governments, in a statement called the deal "a strong outcome for the communities harmed by this crisis".

Persons: painkiller OxyContin, George Frey, Aelish Baig, McKinsey, Joe Biden's, Purdue Pharma's, Nate Raymond, Miral Organizations: Purdue Pharma, REUTERS, Companies Mckinsey, Company, Consulting, McKinsey, Co, U.S . Centers for Disease Control, U.S, Supreme, Purdue, Thomson Locations: Provo , Utah, U.S, San Francisco, United States, Boston

Louis Milione retired from the DEA a second time this summer amid reporting by The Associated Press on potential conflicts caused by his prior consulting for the pharmaceutical industry. Milione had spent four years at Guidepost prior to his return, leveraging his extensive experience and contacts from a 21-year DEA career. “Should we say Welcome Back?” Guidepost quipped in a social media post this week announcing Milione’s rehire as president of global investigations and regulatory compliance. His career stands out for two cycles through the revolving door between government and industry, raising questions about the potential impact on the DEA’s mission to police drug companies blamed for tens of thousands of American overdose deaths. Morris & Dickson is still challenging the ruling, which threatens to put the $4 billion a year company out of business.

Persons: Louis Milione, Milione, Anne Milgram’s, “, ” Guidepost, Milione’s rehire, they’re, ”, Jeff Hauser, Viktor Bout, rehire Milione, Milgram, Lou Milione, Morris, Dickson, ” Milgram Organizations: WASHINGTON, Enforcement, Purdue Pharma, Associated Press, Guidepost Solutions, Justice, DEA’s, Dickson Co, DEA, AP, Morris, Department of Justice Locations: New York, America, Shreveport , Louisiana, Investigative@ap.org

Search resuls for: "Purdue Pharma"

25 mentions found